Back to News
Market Impact: 0.45

Perdoceo Education: The Value Play In EdTech

PRDODAOSTRAAFYAUTICOUR
Analyst InsightsCompany FundamentalsCorporate EarningsCorporate Guidance & OutlookCapital Returns (Dividends / Buybacks)M&A & RestructuringCybersecurity & Data PrivacyRegulation & Legislation
Perdoceo Education: The Value Play In EdTech

Perdoceo Education (PRDO) is rated a Buy, presenting a compelling investment case driven by a strong growth outlook with projected 22.8% revenue growth and 10% EPS growth by FY2025. This growth is fueled by the recent St. Augustine Healthcare University acquisition and organic enrollment gains, despite Q2 showing a 25% revenue increase alongside margin compression from integration costs. Trading at a discounted 12.6x forward P/E versus a 25.7x peer average and 16.5x sector median, PRDO is considered undervalued, further supported by an ongoing share repurchase program and a 1.89% dividend yield. Key risks include potential regulatory changes in the for-profit education sector and ongoing legal implications from a recent data breach.

Analysis

Perdoceo Education (PRDO) presents a clear value and growth thesis, underpinned by its recent acquisition of the University of St. Augustine for Health Sciences (USAHS). The company projects robust full-year revenue growth of 22.8%, fueled by an immediate $36.7MM contribution from USAHS in Q2 and sustained organic enrollment momentum, which grew 17.4% year-to-date. This top-line strength, however, is contrasted by recent margin compression; Q2 results showed gross margin falling 5.5 percentage points and net margin declining 3.47 percentage points due to USAHS integration costs, increased marketing spend, and a $1.49MM rise in interest expense from a sale-leaseback financing liability. Despite this, the forward outlook remains positive with a projected 10% EPS growth for FY2025, supported by a $50 million share repurchase program—of which $46.1 million has already been executed—and a TTM net margin of 20% that significantly outperforms the sector median. The stock's primary appeal lies in its valuation, trading at a 12.6x forward P/E, a substantial discount to its peer average of 25.7x and the sector median of 16.5x. This valuation gap exists alongside catalysts including a 1.89% dividend yield and anticipated synergies from the USAHS integration. Key risks that temper the outlook are the inherent vulnerability of the for-profit education sector to regulatory changes and the unquantified financial and reputational impact from an ongoing investigation into a recent data breach.